Team
Years of research, clinical, operational and investment success give the RiverVest® team an edge in identifying life science innovations that present the greatest potential for commercialization.
Together, we work diligently and consistently to apply our deep domain expertise and strong industry relationships to help entrepreneurs drive their companies forward.
![]() |
![]() |
![]() |
![]() |
![]() |
| Jay W. Schmelter Managing Director |
Thomas C. Melzer Managing Director |
J. Gordon Foulkes, Ph.D. Managing Director |
John McKearn, Ph.D. Venture Partner |
Dennis W. Wahr, M.D. Venture Partner |
![]() |
![]() |
![]() |
![]() |
![]() |
| Karen Spilizewski Vice President |
Niall O’Donnell, Ph.D. Principal |
Poppy J. Keller Financial Associate |
Andrew B. Craig III Special Limited Partner |
Marilyn J. Slavich Controller |
![]() |
![]() |
|||
| Kelly K. Cathey Office Manager |
Corrin J. Short Executive Assistant |
Scientific & Industry Advisory Board
![]() |
![]() |
![]() |
![]() |
![]() |
| Michael Berman | Floyd E. Bloom, M.D. | Joseph M. Davie, M.D., Ph.D. | Nancy J. Hutson, Ph.D. | William A. Peck, M.D. |

















